Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Pichler

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|June 17, 2018
No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of lifeAnne M Plomgaard, Thomas Alderliesten, Frank van Bel, et al.
Pediatric Research|November 17, 2015
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessmentsAnne M Plomgaard, Cornelia Hagmann, Thomas Alderliesten, et al.
Plos One|November 8, 2014
Protective ventilation of preterm lambs exposed to acute chorioamnionitis does not reduce ventilation-induced lung or brain injurySamantha K Barton, Timothy J M Moss, Stuart B Hooper, et al.
Plos One|March 23, 2017
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trialAnne M Plomgaard, Thomas Alderliesten, Topun Austin, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 10, 2015
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readingsJoan Riera, Simon Hyttel-Sorensen, María Carmen Bravo, et al.
Pediatric Research|December 19, 2015
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injuryAnne M Plomgaard, Wim van Oeveren, Tue H Petersen, et al.
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
Danish Medical Journal|January 24, 2013
Clinical use of cerebral oximetry in extremely preterm infants is feasibleSimon Hyttel-Sørensen, Topun Austin, Frank van Bel, et al.
BMJ (Clinical Research Ed.)|January 9, 2015
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trialSimon Hyttel-Sorensen, Adelina Pellicer, Thomas Alderliesten, et al.
Trials|December 21, 2019
Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infantsMathias Lühr Hansen, Adelina Pellicer, Christian Gluud, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Acta Paediatrica (Oslo, Norway : 1992)|June 17, 2018
No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of lifeAnne M Plomgaard, Thomas Alderliesten, Frank van Bel, et al.
Pediatric Research|November 17, 2015
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessmentsAnne M Plomgaard, Cornelia Hagmann, Thomas Alderliesten, et al.
Plos One|November 8, 2014
Protective ventilation of preterm lambs exposed to acute chorioamnionitis does not reduce ventilation-induced lung or brain injurySamantha K Barton, Timothy J M Moss, Stuart B Hooper, et al.
Plos One|March 23, 2017
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trialAnne M Plomgaard, Thomas Alderliesten, Topun Austin, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 10, 2015
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readingsJoan Riera, Simon Hyttel-Sorensen, María Carmen Bravo, et al.
Pediatric Research|December 19, 2015
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injuryAnne M Plomgaard, Wim van Oeveren, Tue H Petersen, et al.
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
Danish Medical Journal|January 24, 2013
Clinical use of cerebral oximetry in extremely preterm infants is feasibleSimon Hyttel-Sørensen, Topun Austin, Frank van Bel, et al.
BMJ (Clinical Research Ed.)|January 9, 2015
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trialSimon Hyttel-Sorensen, Adelina Pellicer, Thomas Alderliesten, et al.
Trials|December 21, 2019
Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infantsMathias Lühr Hansen, Adelina Pellicer, Christian Gluud, et al.
Pageof 19